RACHEL KOCH: Open Payments
NPI 1295431807 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 15 payments from 10 companies in 2025. Trend: 2023 $48 · 2024 $244 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $71 |
| Janssen Biotech, Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Caris MPI, Inc. | 1 | $20 |
| Exelixis Inc. | 1 | $17 |
Products named: Vanflyta, ERLEADA, VOQUEZNA, MONOFERRIC, Trodelvy, Lenvima, OJJAARA, MI CANCER SEEK.
Industry payments across PA — which companies pay providers there.
